MATCH Arm EAY131-U

**Semantic type:** Intellectual Product

**Definition:** The unique identifier assigned to the arm of the Molecular Analysis for Therapy Choice (MATCH) phase II clinical trial that is investigating treatment with defactinib in patients with cancers that have NF2 loss of expression mutations.

**Synonyms:** - EAY131-U - U